Firms/companies
Sahara spends Rs31 lakh on Roy’s failed 5-star Tihar negotiations
01 Nov 2014
The Sahara group paid Rs31lakh on its chairman Subrata Roy’s stay in an air-conditioned conference room with services such as telephone, internet and video conferencing facility in Delhi’s Tihar Jail
Sahara spends Rs31 lakh on Roy’s failed 5-star Tihar negotiations
01 Nov 2014
The Sahara group paid Rs31lakh on its chairman Subrata Roy’s stay in an air-conditioned conference room with services such as telephone, internet and video conferencing facility in Delhi’s Tihar Jail
JLR restarts engine manufacturing in UK after 18 years with new £500-mn plant
31 Oct 2014
The new centre will manufacture the fuel-efficient Ingenium engines, which will power a new generation of Jaguar Land Rover cars, starting with the 2.0-litre Jaguar XE diesel car
Bosch chief sees strong business growth in India
31 Oct 2014
Bosch chief sees strong business growth in India
31 Oct 2014
Nokia shutters its Chennai plant; workers get Rs7.5 lakh package
31 Oct 2014
Nokia's Chennai plant has been forced to shut down after Microsoft Corporation, which bought out Nokia’s entire mobile phone business in September last year, excluded the Chennai plant due to a pending tax litigation between the government and Finnish company
Nokia shutters its Chennai plant; workers get Rs7.5 lakh package
31 Oct 2014
Nokia's Chennai plant has been forced to shut down after Microsoft Corporation, which bought out Nokia’s entire mobile phone business in September last year, excluded the Chennai plant due to a pending tax litigation between the government and Finnish company
EXL acquires Overland Solutions
31 Oct 2014
EXL acquires Overland Solutions
31 Oct 2014
KPMG to bring World Economic Forum live to India
31 Oct 2014
Cipla wants Novartis’s patents on respiratory drug revoked
30 Oct 2014
Cipla, which launched a generic version of the drug, said Novartis imports "negligible quantity" of its patented drug Onbrez from Switzerland, thereby creating a supply shortage at a time when 15 million Indians needed treatment for chronic obstructive pulmonary disease
Cipla wants Novartis’s patents on respiratory drug revoked
30 Oct 2014
Cipla, which launched a generic version of the drug, said Novartis imports "negligible quantity" of its patented drug Onbrez from Switzerland, thereby creating a supply shortage at a time when 15 million Indians needed treatment for chronic obstructive pulmonary disease
Cipla wants Novartis’s patents on respiratory drug revoked
30 Oct 2014
Cipla, which launched a generic version of the drug, said Novartis imports "negligible quantity" of its patented drug Onbrez from Switzerland, thereby creating a supply shortage at a time when 15 million Indians needed treatment for chronic obstructive pulmonary disease